She will take the drug just about every two months at her psychiatrist's office although reclining in a cushty chair. Sure, ketamine for depression remains to be in testing. An Oct 2023 push launch because of the FDA reiterates that ketamine just isn't FDA approved for psychiatric treatment beyond intranasal https://ketnod.co/product/ketamine-for-depression/